Skip to Main Content

Advertisement intended for health care professionals

Umbrella Alt Text
Cart
header search
Search
Skip Nav Destination

Issue Archive

Volume 127, Issue 17
April 28 2016
Issue Cover

Table of Contents

EDITORIAL

Introduction to a review series: the paradox of indolent B-cell lymphoma
Clinical Trials & Observations
Laurie H. Sehn
View Articletitled, Introduction to a review series: the paradox of indolent B-cell lymphoma

BLOOD FLASHBACK

Mannick JA, Lochte HL Jr, Ashley CA, Thomas ED, Ferrebee JW. Autografts of bone marrow in dogs after lethal total-body radiation. Blood. 1960;15(2):255-266.
View Articletitled, Mannick JA, Lochte HL Jr, Ashley CA, Thomas ED, Ferrebee JW. Autografts of bone marrow in dogs after lethal total-body radiation. <em>Blood</em>. 1960;15(2):<span class="related-article">255-266</span>.

INSIDE BLOOD COMMENTARIES

INSIDE BLOOD COMMENTARY
Glucocorticoid selection for pediatric ALL
Clinical Trials & Observations
Stephen P. Hunger
View Articletitled, Glucocorticoid selection for pediatric ALL
INSIDE BLOOD COMMENTARY
HLH susceptibility: genetic lesions add up
Marie Meeths,Yenan T. Bryceson
View Articletitled, HLH susceptibility: genetic lesions add up
INSIDE BLOOD COMMENTARY
Not all subclones matter in CLL
Lesley-Ann Sutton,Richard Rosenquist
View Articletitled, Not all subclones matter in CLL

REVIEW SERIES

Follicular lymphoma: evolving therapeutic strategies
Clinical Trials & Observations
Brad S. Kahl,David T. Yang
View Articletitled, Follicular lymphoma: evolving therapeutic strategies
Optimizing therapy for nodal marginal zone lymphoma
Clinical Trials & Observations
Catherine Thieblemont,Thierry Molina,Frédéric Davi
View Articletitled, Optimizing therapy for nodal marginal zone lymphoma
Splenic marginal zone lymphoma: from genetics to management
Clinical Trials & Observations
Luca Arcaini,Davide Rossi,Marco Paulli
View Articletitled, Splenic marginal zone lymphoma: from genetics to management
The spectrum of MALT lymphoma at different sites: biological and therapeutic relevance
Clinical Trials & Observations
Emanuele Zucca,Francesco Bertoni
View Articletitled, The spectrum of MALT lymphoma at different sites: biological and therapeutic relevance
The role of autologous and allogeneic stem cell transplantation in the management of indolent B-cell lymphoma
Clinical Trials & Observations
John Kuruvilla
View Articletitled, The role of autologous and allogeneic stem cell transplantation in the management of indolent B-cell lymphoma

CLINICAL TRIALS AND OBSERVATIONS

Dexamethasone vs prednisone in induction treatment of pediatric ALL: results of the randomized trial AIEOP-BFM ALL 2000
Clinical Trials & Observations
Anja Möricke,Martin Zimmermann,Maria Grazia Valsecchi,Martin Stanulla,Andrea Biondi,Georg Mann,Franco Locatelli,Giovanni Cazzaniga,Felix Niggli,Maurizio Aricò,Claus R. Bartram,Andishe Attarbaschi,Daniela Silvestri,Rita Beier,Giuseppe Basso,Richard Ratei,Andreas E. Kulozik,Luca Lo Nigro,Bernhard Kremens,Jeanette Greiner,Rosanna Parasole,Jochen Harbott,Roberta Caruso,Arend von Stackelberg,Elena Barisone,Claudia Rössig,Valentino Conter,Martin Schrappe
View Articletitled, Dexamethasone vs prednisone in induction treatment of pediatric ALL: results of the randomized trial AIEOP-BFM ALL 2000
Supplemental data

IMMUNOBIOLOGY

Polygenic mutations in the cytotoxicity pathway increase susceptibility to develop HLH immunopathology in mice
Fernando E. Sepulveda,Alexandrine Garrigue,Sophia Maschalidi,Meriem Garfa-Traore,Gaël Ménasché,Alain Fischer,Geneviève de Saint Basile
View Articletitled, Polygenic mutations in the cytotoxicity pathway increase susceptibility to develop HLH immunopathology in mice
Supplemental data

LYMPHOID NEOPLASIA

Clinical impact of clonal and subclonal TP53, SF3B1, BIRC3, NOTCH1, and ATM mutations in chronic lymphocytic leukemia
Clinical Trials & Observations
Ferran Nadeu,Julio Delgado,Cristina Royo,Tycho Baumann,Tatjana Stankovic,Magda Pinyol,Pedro Jares,Alba Navarro,David Martín-García,Sílvia Beà,Itziar Salaverria,Ceri Oldreive,Marta Aymerich,Helena Suárez-Cisneros,Maria Rozman,Neus Villamor,Dolors Colomer,Armando López-Guillermo,Marcos González,Miguel Alcoceba,Maria José Terol,Enrique Colado,Xose S. Puente,Carlos López-Otín,Anna Enjuanes,Elías Campo
View Articletitled, Clinical impact of clonal and subclonal <em>TP53</em>, <em>SF3B1</em>, <em>BIRC3</em>, <em>NOTCH1</em>, and <em>ATM</em> mutations in chronic lymphocytic leukemia
Supplemental data

MYELOID NEOPLASIA

Normal ABL1 is a tumor suppressor and therapeutic target in human and mouse leukemias expressing oncogenic ABL1 kinases
Yashodhara Dasgupta,Mateusz Koptyra,Grazyna Hoser,Kanchan Kantekure,Darshan Roy,Barbara Gornicka,Margaret Nieborowska-Skorska,Elisabeth Bolton-Gillespie,Sabine Cerny-Reiterer,Markus Müschen,Peter Valent,Mariusz A. Wasik,Christine Richardson,Oliver Hantschel,Heiko van der Kuip,Tomasz Stoklosa,Tomasz Skorski
View Articletitled, Normal ABL1 is a tumor suppressor and therapeutic target in human and mouse leukemias expressing oncogenic ABL1 kinases
Supplemental data

RED CELLS, IRON, AND ERYTHROPOIESIS

A dynamic intron retention program in the mammalian megakaryocyte and erythrocyte lineages
e-blood
Christopher R. Edwards,William Ritchie,Justin J.-L. Wong,Ulf Schmitz,Robert Middleton,Xiuli An,Narla Mohandas,John E. J. Rasko,Gerd A. Blobel
View Articletitled, A dynamic intron retention program in the mammalian megakaryocyte and erythrocyte lineages
Supplemental data

TRANSPLANTATION

Targeted Rho-associated kinase 2 inhibition suppresses murine and human chronic GVHD through a Stat3-dependent mechanism
Ryan Flynn,Katelyn Paz,Jing Du,Dawn K. Reichenbach,Patricia A. Taylor,Angela Panoskaltsis-Mortari,Ante Vulic,Leo Luznik,Kelli K. P. MacDonald,Geoffrey R. Hill,Melanie S. Nyuydzefe,Jonathan M. Weiss,Wei Chen,Alissa Trzeciak,Jon S. Serody,Ethan G. Aguilar,William J. Murphy,Ivan Maillard,David Munn,John Koreth,Corey S. Cutler,Joseph H. Antin,Jerome Ritz,Samuel D. Waksal,Alexandra Zanin-Zhorov,Bruce R. Blazar
View Articletitled, Targeted Rho-associated kinase 2 inhibition suppresses murine and human chronic GVHD through a Stat3-dependent mechanism
Supplemental data

LETTERS TO BLOOD

Spatially divergent clonal evolution in multiple myeloma: overcoming resistance to BRAF inhibition
Marc S. Raab,Nicola Lehners,Jing Xu,Anthony D. Ho,Peter Schirmacher,Hartmut Goldschmidt,Mindaugas Andrulis
View Articletitled, Spatially divergent clonal evolution in multiple myeloma: overcoming resistance to BRAF inhibition
Supplemental data
The level of blast CD33 expression positively impacts the effect of gemtuzumab ozogamicin in patients with acute myeloid leukemia
Clinical Trials & Observations
Guillaume Olombel,Estelle Guerin,Julien Guy,Jean-Yves Perrot,Florent Dumezy,Adrienne de Labarthe,Jean-Noël Bastie,Ollivier Legrand,Emmanuel Raffoux,Adriana Plesa,Orianne Wagner-Ballon,Edouard Cornet,Véronique Salaun,Claude Preudhomme,Xavier Thomas,Cécile Pautas,Sylvain Chantepie,Pascal Turlure,Sylvie Castaigne,Hervé Dombret,Jean Feuillard
View Articletitled, The level of blast CD33 expression positively impacts the effect of gemtuzumab ozogamicin in patients with acute myeloid leukemia
Supplemental data

BLOOD WORK

Peripheral blood findings in GM1 gangliosidosis
David T. Lynch,David R. Czuchlewski
View Articletitled, Peripheral blood findings in GM1 gangliosidosis
All Issues

Advertisement intended for health care professionals

Let’s YAP about ITP
Location, location, location: EMD in MM
Ruxolitinib REACHes FOR children with GVHD
Oxidative hemolysis due to phenazopyridine in the absence of G6PD deficiency
Hemoglobin-based transfusion strategies for cardiovascular and other diseases: restrictive, liberal, or neither?

Advertisement intended for health care professionals

Advertisement intended for health care professionals

  • American Society of Hematology
  • 2021 L Street NW, Suite 900
  • Washington, DC 20036
  • TEL +1 202-776-0544
  • FAX +1 202-776-0545

ASH Publications

American Society of Hematology

Copyright 2024 by American Society of Hematology
 
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals